GH Research PLC - stock earnings
GHRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -11.3 million USD | ? USD |
| 2023Q3 | -5.6 million USD | ? USD |
| 2023Q2 | -7.7 million USD | ? USD |
| 2023Q1 | -12.1 million USD | ? USD |
| 2022Q4 | -16.8 million USD | ? USD |
| 2022Q3 | 5.7 million USD | ? USD |
| 2022Q2 | 7.4 million USD | ? USD |
| 2022Q1 | -3.5 million USD | ? USD |
| 2021Q4 | -4.1 million USD | ? USD |
| 2021Q3 | -1.8 million USD | ? USD |
| 2021Q2 | -2.1 million USD | ? USD |
| 2021Q1 | -1.1 million USD | ? USD |
| 2020Q4 | -325000 USD | ? USD |
| 2020Q3 | -60000 USD | ? USD |
| 2020Q2 | -42000 USD | ? USD |
| 2020Q1 | -19000 USD | ? USD |
GHRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -35.6 million USD | ? USD |
| 2022 | -7.1 million USD | ? USD |
| 2021 | -9.2 million USD | ? USD |
| 2020 | -446000 USD | ? USD |
| 2019 | -310000 USD | ? USD |
GHRS
Price: $11.68
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: -10.13
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 6316
Market Capitalization: 582.2 million